Articles

{ DOWNLOAD AS PDF }

ABOUT AUTHOR
JY Manure, NS Naikwade
Department Of Pharmaceutical Chemistry
Appasaheb Birnale College of Pharmacy,
Sangli, Maharashtra, India
Javeedmanure.98600@yahoo.com

ABSTRACT 
Cancer is a diseases characterized by out-of-control cell growth. There are various types of cancer, and is classified by the type of cell that is affected. Cancer harms the body when altered cells divide uncontrollably to form lumps or masses of tissue called tumors. The recent treatments include chemotherapy, radiotherapy and Surgery. But this treatment accomplished by several side effect like the destruction of bone marrow cell, alopecia etc. So there is a need for the new drug for treatment of cancer. Plant-derived chemical may act as anticancer in many studies. The Plant produces secondary metabolites which are being evaluated for the anticancer activities leading to the development of new drugs. So in this review we have study different plants which act as anticancer. And this will encourage further scientific study of traditionally used plants.

ABOUT AUTHORS
Devender Sharma*¹, Deepika Sarkar^1
1Hi – Tech College of Pharmacy, Chandrapur, Maharashtra (India)
^*sdevender350@gmail.com
{ DOWNLOAD AS PDF }

ABSTRACT
Tuberculosis is a hypersensitive granulomatous infectious disease caused by Mycobacterium Tuberculosis (M.TB).In India 40% people are affected by T.B. So need of knowledge about T.B.  and pathophysiology of T.B. to people or society. Pathophysiology means, when a human being or animal being suffering from a disease this is because deranged or change in function on that organ or human body.  Infection is caused by air- borne droplets of organisms person to person. The main object of this review is how to diagnose and how it is cure or treat. It is diagnosed by PPD, IGRA, Sputum studies, X-rays and Biopsies. Mostly antibiotics are preferred for the first treatment.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
U.Swathi lakshmi¹,  K.Revathi¹ , Dr.P.Shailaja¹, Prof.J.Vijaya Ratna¹, Blessy A. Daniel², Dr.Prashanth.S.^2
1Andhra University College of Pharmaceutical Sciences, Visakhapatnam
²S3V Vascular technologies Pvt.Ltd, Bangalore

ABSTRACT:
The New Medical Device Regulations of European Union replace the E.U’s current Medical Device Directive (93/42/EEC) and the E.U’s Directive on Active Implantable Medical Devices (90/385/EEC) According to the draft document, NB’s would be placed under a strict regimen of super vision, although it remains unclear whether the intended sanctions could be implemented against the will of a Member State, should the need occur. The qualification requirements for auditing and reviewing NB staff are steeply increased. Greater emphasis will be placed on clinical data and the Clinical Evaluation. For implantable medical devices and Class III devices clinical investigations will be expected since equivalence will generally no longer be an acceptable approach, although some exceptions can be made. The proposed MDR attempts to make more transparent the periods for review by various parties for different activities. Implementation of Unique device identification helpful for the unambiguous identification of a specific device on the market.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
SMRUTIPRAGNYA SAMAL, PRATYUSH KUMAR DAS*
Centre for Biotechnology, Siksha ‘O’ Anusandhan University, Bhubaneswar, Odisha, India – 751003
*pratyushdas@soauniversity.ac.in

ABSTRACT
Microbial biofilms are complex structures wherein the planktonic cells change their growth mode to the sessile form. This kind of growth is assisted by the formation of a matrix of extracellular polymeric substances (EPS) which encapsulates the bacterial cells within it and thus, provides an additional protection. These biofilms are highly resistant to high concentration of antibiotics and poses a great threat towards public health. These biofilms are even beyond the access of a normal human immune system and are involved in infections of teeth, lungs and many other diseases. There lies an immediate need to replace the extensive use of antibiotics with new emerging strategies. The review intends to provide an insight on the various perspectives of microbial biofilms including their formation, composition, mechanism of communication (Quorum sensing) and pathogenicity. Recent emerging strategies have also been discussed that can be considered for successful eradication or inhibition of biofilms and related infections.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
RAMYA MADHIRI¹, G. VIJAYALAKSHMI^2
1Department of Pharmacognosy and Phytochemistry, AU college of Pharmaceutical Sciences, Andhra University, Visakhapatnam - 530 003.
²Department of Biotechnology, GIT,  GITAM University, Visakhapatnam -530 045
*ramyapraveen2709@gmail.com

ABSTRACT
Herbal medicines contribute a major share of officially recognized health care systems. Scientific research was trending on the isolation of active compounds of herbal origin. The present review concentrate on important species, active constituents, pharmacological aspects, identification tests for active constituents and the important research work carried out on the genus   Alstonia which may be helpful for the future research work.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Nayan Jain*, Ashutosh Biswas, Kratika Vivek Daniel
Mandsaur Institute of pharmacy,
Mandsaur, MP, India
*nayanofficial499@gmail.com

ABSTRACT
Today the world has suffered to the Zika virus is a flavivirous related to yellow fever, dengue, West Nile and Japanese encephalis virus. Zika virus causes acute, serious illness which is often fatal if it is not treated. Its name comes from the Zika forest of Uganda. Zika is a mosquito born disease. Zika virus disease is caused by a virus transmitted primarily by Aedes mosquitoes. People with Zika virus disease can have symptoms including mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or headache. These symptoms normally last for 2-7 days. There is scientific consensus that Zika virus is a cause of microcephaly and Guillain-Barré syndrome. Links to other neurological complications are also being investigated. Neither an effective treatment nor a vaccine is available for Zika virus; therefore, the public health response primarily focuses on preventing infection, particularly in pregnant women. These article also covers from where the zika was firstly introduced or its history, its transmissions, causes, diagnosis, treatment and some current affairs.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Dr. M. Manasa Rekha1*, Dr.M.Manasa², C.Reddy Kumari^2
1*,² Doctor of pharmacy, Department of Pharmacy Practice,
Annamacharya college of Pharmacy,
Rajampet, Kadapa, Andhra Pradesh, India.
*manasarekharoyal@gmail.com

ABSTRACT:
Poly-Cystic Ovary Syndrome (PCOS) is characterized by multiple small ovarian cysts, obesity, hypertension, diabetes, insulin resistance, and Hirsutism. The Study Aims to assess the role of Doctor Of Pharmacy in identification of risk factors in developing poly cystic ovarian syndrome among teenagers and minimizing them by life style modifications through advanced Patient counseling.The Main Objective of the present study is to prevent the following: To prevent the complications of PCOS who are suffering with PCOS in early of their age. To prevent the occurrence of PCOS to early females who are nearer for its occurrence. To minimize the symptoms and to improve the quality of life of females suffering with PCOS. Study Design: It is a observational and interventional study. Study Period: The Present study was conducted for a period of 6 months from January 2nd  2017 to July 31st 2017.Study site : The Present study was conducted in BAHUDHA WOMENS HOSTEL affiliated to Annamacharya college of Pharmacy, Rajampet, Kadapa, Andhra Pradesh, India. In The Present Study Out of total 600 women   530 enrolled to participate in the present study. After the collection of information by PCOS  self assessment forms the scoring is given as 271 with scoring >5 with percentile 51.1320 are with Chance for getting PCOS, 159 with scoring > 10with percentile 30.01 are with high Chance for getting PCOS, 100 with scoring  <5with percentile 18.8679 are Unpredictable to PCOS. The present study concludes that Doctor Of Pharmacy is very helpful in assessing the risk factors responsible in developing PCOS and also minimizing them by life style modifications through advanced patient counseling.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Nabadoy Roy*, Suprodip Mandal, Beduin Mahanti, Sandipan Dasgupta*
Division of Pharmacology, Department of Pharmacy,
Bharat Technology, Uluberia, Howrah 711316,
*n.roy.santoshpur@gmail.com

ABSTRACT
Objective:  The aim of this present study is to evaluate the activity of green tea extracted in different solvents on different microorganism such as on Staphylococcus aureus ATCC 6538, Escherichia coli ATCC 8739, Salmonella abony NCTC 6017, Pseudomonas aeruginosa ATCC 9027, Candida albicans ATCC 10231, Esteritia coli mutant NCIM 2567, Bacillus subtilis ATCC 6633 &Lactobacillus lichmani ATCC 7830.
Method:  Zone of inhibition of aqueous, methanolic and ethanolic extracts were measured and compared by using cup plate method. 5µg, 10µg, 15µg & 20µg concentration of the extract were used. MIC (Minimum inhibitory concentration)& MBC (Minimum bactericidal concentration ) were observed with the concentrations of 100µg, 75µg, 50µg & 25µg.
Result: Result of zone of inhibition shows that aquous extract at the concentration of 20µg/ml is most effective to inhibit Escherichia coli growth compare to standard.Also minimum inhibitory concentration (MIC) & minimum bactericidal concentration (MBC) result suggest that aquous extract is more effective than ethanolic and methanolic extract to inhibit the growth of both Escherichia coli &Escherichia coli mutant.
Conclusion: Significant antimicrobial activity has been shown by all extracts against Escherichia coli but other microorganism inhibition is not so significant compare to Escherichia coli. Methanolic and ethanolic extract has shown little antimicrobial activity against all microorganisms as compared to the aqueous extract.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Devender Sharma1*, Ameya Lanjewar2
¹Department of Pharmaceutics, Hi-Tech College of Pharmacy, Chandrapur India
²Department of Pharmaceutics, Kamala Nehru College of Pharmacy, Butibori Nagpur India
*sdevender350@gmail.com

ABSTRACT
Ibuprofen largely used in various disorders  treatment likely to be  rheumatoid arthritis, osteoarthritis and other musculoskeletal disorders, especially where pain is more prominent than inflammation. Ibuprofen is used as a simple analgesic, antipyretic and it is particularly effective in dysmenorrheal. By the process of Moisture activated dry granulation, Ibuprofen tablets prepared but these method prepared tablets do not give better drug content, drug release. So formulation optimize by full factorial i.e. change in various polymer concentration like SSG and Povidone at three different levels. Ibuprofen tablets manufactured by moisture activated dry granulation method with optimization show better drug release, drug stability in comparison of marketed preparation. Due to optimization, Ibuprofen tablets which manufactured by moisture activated dry granulation method have very low cost in comparison of marketed preparation. The main objective of this research work water poorly soluble drug like ibuprofen tablet manufactured by moisture activated dry granulation by optimize process gives better drug release, manufacture cost also less other than marketed tablets.